919 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
TEVA Teva Pharmaceutical Industries Limited $23.43 $23.86B N/A
Article Searches
Teva (TEVA) Q1 Earnings In-Line, Sales Miss, Shares Up http://www.zacks.com/stock/news/260199/teva-teva-q1-earnings-in-line-sales-miss-shares-up?cid=CS-ZC-FT-260199 May 11, 2017 - Teva???s first quarter earnings (including equity compensation expenses), came in at $1.03 per share, in-line with the consensus estimate.
Teva Pharmaceutical Industries Limited 2017 Q1 - Results - Earnings Call Slides https://seekingalpha.com/article/4072115-teva-pharmaceutical-industries-limited-2017-q1-results-earnings-call-slides?source=feed_sector_healthcare May 11, 2017 - The following slide deck was published by Teva Pharmaceutical Industries Limited in conjunction with their 2017 Q1 earnings call.
Early movers: STRP, SNAP, FOXA, WFM, KSS, TEVA, YUM & more http://www.cnbc.com/2017/05/11/early-movers-strp-snap-foxa-wfm-kss-teva-yum-more.html May 11, 2017 - Names on the move ahead of the open.
4 Pressing Questions We Want Answered When Teva Pharmaceutical Reports Tomorrow Morning https://www.fool.com/investing/2017/05/10/4-pressing-questions-we-want-answered-when-teva-ph.aspx?source=iedfolrf0000001 May 10, 2017 - From Copaxone's patents to its $35.8 billion in debt, shareholders have questions and we want answers.
Mylan vs. Teva: Which Is the Better Generics Stock Ahead of Earnings? http://www.zacks.com/stock/news/259970/mylan-vs-teva-which-is-the-better-generics-stock-ahead-of-earnings?cid=CS-ZC-FT-259970 May 09, 2017 - Mylan and Teva are scheduled to report on May 10 and May 11
Allergan (AGN) Beats Q1 Earnings Estimates, Ups 2017 View http://www.zacks.com/stock/news/259943/allergan-agn-beats-q1-earnings-estimates-ups-2017-view?cid=CS-ZC-FT-259943 May 09, 2017 - Allergan plc's (AGN) first-quarter 2017 earnings came in at $3.35 per share, beating the Zacks Consensus Estimate of $3.32 by 0.9%.
Express Scripts launches drug discount subsidiary http://feeds.bizjournals.com/~r/industry_6/~3/_GV-zKppSHY/express-scripts-launches-drug-discount-subsidiary.html May 08, 2017 - Express Scripts is partnering with a California-based drug discount program to launch Inside Rx, a new subsidiary focused on lowering out-of-pocket costs for prescription medications. Inside Rx, which is partially owned by Express Scripts, will deliver average savings of 34 percent on prescription drugs for those who do not have insurance or have plans with high deductibles, according to an announcement about the program. Express Scripts is teaming up with Santa Monica, California-based GoodRx on…
Teva Pharmaceutical (TEVA) Q1 Earnings: What's in the Cards? http://www.zacks.com/stock/news/259711/teva-pharmaceutical-teva-q1-earnings-whats-in-the-cards?cid=CS-ZC-FT-259711 May 08, 2017 - Teva Pharmaceutical Industries Ltd. (TEVA) is scheduled to report first-quarter 2017 earnings on May 11
Pharma Stock Roundup: Merck, Pfizer Report Q1 Earnings, J&J Talc Powder Lawsuit http://www.zacks.com/stock/news/259676/pharma-stock-roundup-merck-pfizer-report-q1-earnings-jj-talc-powder-lawsuit?cid=CS-ZC-FT-259676 May 08, 2017 - Major pharma companies like Pfizer (PFE) and Merck reported Q1 results last week.
Teva: Conservatively Bottom-Fishing For Extra Income - Even If Recovery Is Far Off https://seekingalpha.com/article/4069132-teva-conservatively-bottom-fishing-extra-income-even-recovery-far?source=feed_tag_israel May 04, 2017 - Beleaguered Teva shares appear to have 'playable' support at around $30. While the upcoming earnings report of May 11 may be bad, bad enough to break that support, entry at this level for the long ter

Pages: 1...7980818283848586878889...92

<<<Page 84>